Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a ...

Thursday, August 14, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Merck & Co.

M&A deals announced worldwide in July included a rail merger, which is the largest transaction in the past 12 months based on ...

MSD's plan to reduce its headcount by around 6,000, first revealed a couple of weeks ago, looks like it will start at its ...

Finally, add PepsiCo (NASDAQ: PEP) to your list of S&P 500 dividend stocks to buy and hold forever while you can plug into ...

Senator, Dr. Rasha Kelej has been recognized as One of 100 Most Influential Africans for six consecutive years from 2019 till ...

Dividend investing is gaining popularity as more Americans turn to secondary income sources to offset market volatility and ...

Pharmaceutical research and development firms in China are increasingly interested in procuring critical supplies known as reagents from local ...

Two leading cardiology groups have joined forces to position heart failure as a preventable condition, encouraging clinicians ...

The first half of 2025 has seen an acceleration of M&A activity, including large-scale life sciences transactions, such as Merck’s $3.9 ...

The company will instead focus resources on its last remaining clinical asset, PRT7732, a chemically distinct SMARCA2 degrader.

The directive calls for building a six-month Strategic Active Pharmaceutical Ingredients Reserve, updating the essential ...